Stockscreener 앱 받기
3.55
1.14%
0.04
전일 마감가:
$3.51
열려 있는:
$3.54
하루 거래량:
3.48M
Relative Volume:
1.10
시가총액:
$396.32M
수익:
$2.05B
순이익/손실:
$-128.18M
주가수익비율:
-2.2617
EPS:
-1.5696
순현금흐름:
$-68.67M
1주 성능:
+13.06%
1개월 성능:
+16.01%
6개월 성능:
-62.59%
1년 성능:
-58.48%
1일 변동 폭
$3.50
$3.695
1주일 범위
$3.10
$3.695
52주 변동 폭
$2.50
$12.06
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
3.55 | 391.85M | 2.05B | -128.18M | -68.67M | -1.5696 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-11-13 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
Evolent Health (EVH) CFO awarded 429,041 performance share units tied to 2027–2029 stock goals - Stock Titan
EVH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Cowen Maintains Buy on Evolent Health (EVH) March 2026, PT Cut to $7 - Meyka
TD Cowen cuts Evolent Health stock price target to $7 on 2026 outlook - Investing.com Canada
Oppenheimer Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - MarketBeat
Evolent Health (EVH) Receives Updated Analyst Rating from Oppenh - GuruFocus
Oppenheimer Adjusts Evolent Health Price Target to $6 From $12, Maintains Outperform Rating - marketscreener.com
Evolent Health Charts Growth Amid 2026 Margin Squeeze - TipRanks
Privia Health Expands Value Based Care Scale With Evolent ACO Acquisition - Yahoo Finance
Evolent Health (NYSE:EVH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Evolent Health and iRhythm Shares Are Falling, What You Need To Know - Finviz
EVH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Evolent Health Inc affected by consumer sentimentTrade Risk Assessment & Risk Managed Investment Signals - baoquankhu1.vn
Evolent to Participate in Upcoming Investor Conferences - The Malaysian Reserve
EVH: Citigroup Maintains Buy Rating, Lowers Price Target | EVH S - GuruFocus
Evolent Health downgraded at KeyBanc on EBITDA recovery concerns - MSN
Evolent Health (NYSE:EVH) Price Target Lowered to $4.00 at Citigroup - MarketBeat
UBS Maintains Evolent Health (EVH) Rating, Lowers Price Target | - GuruFocus
UBS Group Lowers Evolent Health (NYSE:EVH) Price Target to $5.00 - MarketBeat
Privia Health Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Evolent Health: Cheap, Levered, But Ready To Rebound (NYSE:EVH) - Seeking Alpha
UBS Adjusts Evolent Health Price Target to $5 From $10, Maintains Buy Rating - marketscreener.com
Truist Cuts Price Target on Evolent Health to $6 From $10, Keeps Buy Rating - marketscreener.com
Privia Health (PRVA) Q4 2025 Earnings Transcript - AOL.com
Evolent Health, Inc. (NYSE:EVH) Q4 2025 Earnings Call Transcript - Insider Monkey
Evolent Health (EVH) Shares Skyrocket, What You Need To Know - Finviz
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious - Stocktwits
Truist cuts Evolent Health stock price target to $6 on 2026 outlook - Investing.com Australia
Evolent Health (EVH) Rating Maintained But Price Target Drastica - GuruFocus
Evolent Health (NYSE:EVH) Price Target Lowered to $4.00 at Needham & Company LLC - MarketBeat
RBC Capital Lowers Price Target for Evolent Health (EVH) by 40% - GuruFocus
Royal Bank Of Canada Cuts Evolent Health (NYSE:EVH) Price Target to $3.00 - MarketBeat
RBC Capital Adjusts Evolent Health PT to $3 From $5, Maintains Sector Perform Rating - marketscreener.com
KeyCorp Downgrades Evolent Health (NYSE:EVH) to Sector Weight - MarketBeat
BTIG Research Issues Pessimistic Forecast for Evolent Health (NYSE:EVH) Stock Price - MarketBeat
Evolent Health Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
EVH: Keybanc Downgrades Evolent Health to Sector Weight | EVH St - GuruFocus
This First Solar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Evolent Health, Inc. SEC 10-K Report - TradingView
EVH: BTIG Lowers Price Target to $8, Maintains Buy Rating | EVH Stock News - GuruFocus
EVH | Evolent Health, Inc Class FinancialsIncome Statement - Quiver Quantitative
Evolent Health Q4 Loss Of US$3.84 Per Share Tests Bullish Margin Turnaround Narrative - Sahm
Evolent Health Inc earnings beat by $0.03, revenue fell short of estimates - Investing.com Australia
Evolent Health Q4 Earnings Call Highlights - MarketBeat
KeyBanc downgrades Evolent Health stock rating on leverage concerns - Investing.com Australia
Evolent Health Inc (EVH) Q4 2025 Earnings Call Highlights: Stron - GuruFocus
Evolent Health Q4 2025 Earnings: Revenue Meets Forecasts, EPS Beats EstimatesNews and Statistics - IndexBox
Evolent Health (EVH) Q4 Earnings Top Estimates - Yahoo Finance
Compared to Estimates, Evolent Health (EVH) Q4 Earnings: A Look at Key Metrics - Nasdaq
Evolent Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:EVH) 2026-02-24 - Seeking Alpha
Evolent Health (EVH) outlines specialty care and risk-based growth strategy - Stock Titan
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.25%
1.11%
자본화:
|
볼륨(24시간):